Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 107, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2014-11-29
DOI
10.1093/jnci/dju345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
- (2014) Marlies S. Reimers et al. JAMA Internal Medicine
- Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
- (2013) Reiko Nishihara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Aspirin postdiagnosis improves survival for colon cancer patients
- (2012) E Bastiaannet et al. BRITISH JOURNAL OF CANCER
- Aspirin and other non-steroidal anti-inflammatory drug use and colorectal cancer survival: a cohort study
- (2012) A J Walker et al. BRITISH JOURNAL OF CANCER
- Aspirin Use After Diagnosis Improves Survival in Older Adults with Colon Cancer: A Retrospective Cohort Study
- (2012) Marlies S. Reimers et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- (2011) John Burn et al. LANCET
- The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial
- (2011) Raghib Ali et al. Trials
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
- (2010) A. E. Coghill et al. GUT
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Nonsteroidal anti-inflammatory drugs
- (2009) Jason A. Zell et al. CANCER
- Aspirin Use and Survival After Diagnosis of Colorectal Cancer
- (2009) Andrew T. Chan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epithelial metaplasia: adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation?
- (2009) Michael Herfs et al. TRENDS IN MOLECULAR MEDICINE
- Methylation of Polycomb Target Genes in Intestinal Cancer Is Mediated by Inflammation
- (2008) M. A. Hahn et al. CANCER RESEARCH
- NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
- (2008) Jordi Rius et al. NATURE
- Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas
- (2007) Richard F.A. Logan et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started